Patent intelligence · US
US 10010571
Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof
Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of us…
Patent details — US 10010571
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 3, 2018
- Expiration
- Jun 28, 2038
- Applicant
- Maximum Human Performance, LLC
- Claims
- 8
- CPC classes
- A61K, A61K31/165, A61K36/424, A61K36/704
Quick answer
US 10010571 (Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof) is held by Maximum Human Performance, LLC. Status: granted. Granted Jul 3, 2018. Expires Jun 28, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Maximum Human Performance, LLC
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K31/165, A61K36/424, A61K36/704
More from Maximum Human Performance, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12391732
Articles comprising a silk polypeptide for antigen delivery
granted -
US 12379385
Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
granted -
US 12318397
Methods and compositions for testosterone production
granted -
US 12290524
Methods and compositions for testosterone production
granted -
US 12171837
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 12168718
Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel
granted -
US 12144876
Security mechanisms for radiopharmaceutical elution system and elution process
granted -
US 12133890
Antigen-binding polypeptide targeting B7H3 and application thereof
granted
Frequently asked questions
What is US patent 10010571?
US 10010571 (Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof) is held by Maximum Human Performance, LLC. Status: granted. Granted Jul 3, 2018. Expires Jun 28, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10010571?
Maximum Human Performance, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 138 pharmaceutical patents for this assignee.
When does US 10010571 expire?
Our index shows an expiration date of Jun 28, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.